NIM
ABMD

NuWave Investment Management’s Abiomed Inc ABMD Stock Holding History

NuWave Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-139
Closed -$45K – 432
2021
Q3 		$45K Buy
+139
New +$47.1K 0.05% 245
2020
Q4 		– Sell
-380
Closed -$106K – 545
2020
Q3 		$106K Buy
+380
New +$109K 0.16% 174

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NuWave Investment Management's ABMD Position: Q4 2021 in Review

NuWave Investment Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 139 shares — an estimated $45K sold.

NuWave Investment Management first reported a position in ABMD in Q3 2020 and held it in 2 quarters. The position peaked at $106K in Q3 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • NuWave Investment Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • NuWave Investment Management sold 139 Abiomed Inc shares in Q4 2021, an estimated $45K.
  • NuWave Investment Management first reported a position in Abiomed Inc in Q3 2020 and held it in 2 quarters.
  • NuWave Investment Management's Abiomed Inc position peaked at $106K in Q3 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on NuWave Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.